Results 111 to 120 of about 27,314 (241)

Case report: Rare observation of thyroid-like cholangiocarcinoma

open access: yesFrontiers in Medicine
Intrahepatic cholangiocarcinoma is a highly malignant tumor with a poor prognosis. Radical surgical resection remains the “gold standard” for improving patient outcomes; however, only a minority of patients qualify for this approach.
Ekaterina Bondarenko   +5 more
doaj   +1 more source

Ablative therapies for intrahepatic cholangiocarcinoma

open access: yesHepatoBiliary Surgery and Nutrition, 2018
Among the 3 sub-types of cholangiocarcinoma (CH), [intrahepatic CH, hylar (CH) and extrahepatic (CH)], intrahepatic cholangiocarcinoma (ICC) accounts for up 8–10% of cholangiocarcinomas and 10–20% of all primary liver tumors (1). Interestingly, the occurrence of ICC on cirrhosis is increasing in the last years (2).
Giorgio, Antonio   +3 more
openaire   +5 more sources

Clinical Parameters Predicting Survival Duration after Hepatectomy for Intrahepatic Cholangiocarcinoma

open access: yesCanadian Journal of Gastroenterology, 2011
BACKGROUND: Currently, the most effective treatment for intrahepatic cholangiocarcinoma (ICC) is complete hepatic tumour excision.
Bei-ge Jiang   +5 more
doaj   +1 more source

Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma [PDF]

open access: bronze, 1999
Masayoshi Yamamoto   +2 more
openalex   +1 more source

A Rare Diagnosis of Caroli Syndrome in a Young Patient

open access: yesClinical Case Reports, Volume 13, Issue 6, June 2025.
ABSTRACT Caroli syndrome is a rare but serious congenital disorder associated with portal hypertension and polycystic kidney disease. Early diagnosis via imaging, particularly MRCP, is crucial to prevent life‐threatening complications such as cholangitis and biliary cirrhosis.
Elaheh Karimzadeh‐Soureshjani   +4 more
wiley   +1 more source

Clinical Use of Comprehensive Genomic Profiling Tests in Intrahepatic Cholangiocarcinoma: A Single‐Center Retrospective Study

open access: yesLiver International Communications, Volume 6, Issue 2, June 2025.
ABSTRACT The clinical utility of comprehensive genomic profiling (CGP) in intrahepatic cholangiocarcinoma (ICC) remains to be fully elucidated. This study analysed CGP test results and evaluated treatment outcomes with fibroblast growth factor receptor (FGFR) inhibitors in patients with ICC, aiming to assess their efficacy in cases with specific FGFR ...
Makiko Urabe   +10 more
wiley   +1 more source

Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine

open access: yesCA: A Cancer Journal for Clinicians, Volume 75, Issue 3, Page 226-242, May/June 2025.
Abstract Cancer molecular imaging is the noninvasive visualization of a process unique to or altered in neoplasia, such as proliferation, glucose metabolism, and receptor expression, which is relevant to patient management. Several molecular imaging modalities are now available, including magnetic resonance, optical, and nuclear imaging.
Malik E. Juweid   +6 more
wiley   +1 more source

Ficolin‐3 Activates Complement and Triggers Necroptosis in Cholangiocarcinoma Cells via the RIPK1/RIPK3/MLKL Signaling Pathway

open access: yesThe FASEB Journal, Volume 39, Issue 10, 31 May 2025.
FCN3‐mediated activation of the lectin complement pathway via MASP2 binding induces necroptosis in cholangiocarcinoma cells through the RIPK1/RIPK3/MLKL axis. ABSTRACT Ficolin 3 (FCN3) is a pattern recognition molecule that activates the complement system via the lectin pathway.
Zeyu Zhang   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy